• Users Online: 102
  • Print this page
  • Email this page

    Article Cited by others


Where will non-Vitamin K oral anticoagulants stand beyond being standard of care in anticoagulation therapy?

Ergene Oktay

Year : 2019| Volume: 5| Issue : 3 | Page no: 75-79

   This article has been cited by
1 Novel Drug Interaction index and Risk of Mortality in Older Patients With Atrial Fibrillation Receiving Non Vitamin K Oral Anticoagulants (NOEL Drug)
Ibrahim Ersoy
Clinical and Applied Thrombosis/Hemostasis. 2021; 27: 1076029621
[Pubmed]  [Google Scholar] [DOI]
2 Assessment of the compatibility of the real-world nonvalvular atrial fibrillation patients in Turkey with the study population of Phase 3 novel oral anticoagulant trials: An auxiliary study of NOAC-TR
SadikVolkan Emren,Mehdi Zoghi,Ugur Karagöz,Sinan Inci,Gönül Açiksari,Lütfü Bekar,ZeynepYapan Emren,Oktay Ergene
International Journal of the Cardiovascular Academy. 2020; 6(1): 12
[Pubmed]  [Google Scholar] [DOI]


Read this article